6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension

NCT02140060 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

327

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: Dose Level A / Brinzolamide 1% ophthalmic suspension
DRUG: Dose Level B / Brinzolamide 1% ophthalmic suspension
DRUG: Dose Level C / Brinzolamide 1% ophthalmic suspension
DRUG: Brinzolamide 1% ophthalmic suspension AZOPT®
DRUG: Travoprost 0.004% ophthalmic solution TRAVATAN Z®
DRUG: Travoprost solution vehicle
DRUG: Brinzolamide suspension vehicle

Sponsor

Alcon Research